Sun Y, Cui Z, Sun Y, Qin L, Zhang X et al (2020) Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders
The Right Program Depends on Your Health Goals Amazon's GLP-1 program may be the right fit for some patients seeking general primary care access
Tirzepatide: From Phase 3 to Pharmacy in 2.5 Years Eli Lilly started the SURMOUNT trial program for tirzepatide in late 2020
Some people experience side effects like nausea or decreased appetite, which can lead to dehydration or nutritional gaps
Episodic migraine (4) Source: Clinical Trial Identifier NCT02629861 (4) Chronic migraine (5) Source: Clinical Trial Identifier NCT02621931 (5) These studies show a clinically significant reduction in migraine days for people with both episodic or chronic migraine
CrossRef Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation Huhu Ren, Jian Chen, Zhiqun Wu, Chen Li Frontiers in Oncology .2025;[Epub] CrossRef A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B Jiwon Yang, Mark D